AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionCNB Bank
Latest Disclosed Ownership14,318 shares
Latest Disclosed Value $ 3,114,022
CNB Bank reports 0.10% increase in ownership of ABBV / AbbVie Inc.

On May 6, 2026 - CNB Bank filed a 13F-HR form disclosing ownership of 14,318 shares of AbbVie Inc. (US:ABBV) valued at $3,114,022 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 14,303 shares of AbbVie Inc.. This represents a change in shares of 0.10% during the quarter. The current value of the position is $3,108,867 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ABBVIE COM 00287Y109 14,318 15 0.10 3,114 -4.71 1.2723
2026-02-11 2025-12-31 13F ABBVIE COM 00287Y109 14,303 -102 -0.71 3,268 -2.01 1.3375
2025-10-30 2025-09-30 13F ABBVIE COM 00287Y109 14,405 368 2.62 3,335 28.02 1.3896
2025-07-31 2025-06-30 13F ABBVIE COM 00287Y109 14,037 -315 -2.19 2,606 -13.37 1.2351
2025-04-24 2025-03-31 13F ABBVIE COM 00287Y109 14,352 -1,251 -8.02 3,007 8.48 1.5222
2025-01-15 2024-12-31 13F AbbVie COM 00287Y109 15,603 -414 -2.58 2,773 -12.36 1.2884
2024-10-18 2024-09-30 13F AbbVie COM 00287Y109 16,017 -544 -3.28 3,163 11.37 1.4629
2024-08-08 2024-06-30 13F AbbVie COM 00287Y109 16,561 -2,565 -13.41 2,841 -18.44 1.3665
2024-05-02 2024-03-31 13F AbbVie COM 00287Y109 19,126 -926 -4.62 3,483 12.07 1.6984
2024-01-31 2023-12-31 13F AbbVie COM 00287Y109 20,052 -948 -4.51 3,107 -0.73 1.6685
2023-11-02 2023-09-30 13F AbbVie COM 00287Y109 21,000 631 3.10 3,130 14.07 1.8432
2023-08-08 2023-06-30 13F AbbVie COM 00287Y109 20,369 -535 -2.56 2,744 -17.62 1.6143
2023-05-10 2023-03-31 13F AbbVie COM 00287Y109 20,904 833 4.15 3,331 2.71 2.0276
2023-02-13 2022-12-31 13F AbbVie COM 00287Y109 20,071 -635 -3.07 3,244 16.70 2.0278
2022-11-14 2022-09-30 13F AbbVie COM 00287Y109 20,706 400 1.97 2,779 -10.64 1.8802
2022-08-19 2022-06-30 13F/A-1 AbbVie COM 00287Y109 20,306 -1,602 -7.31 3,110 -12.44 2.0117
2022-08-10 2022-06-30 13F AbbVie COM 00287Y109 21,963 55 3,364 1.3870
2022-04-13 2022-03-31 13F AbbVie COM 00287Y109 21,908 -697 -3.08 3,552 16.04 1.9690
2022-01-31 2021-12-31 13F AbbVie COM 00287Y109 22,605 -386 -1.68 3,061 23.43 1.6772
2021-11-02 2021-09-30 13F AbbVie COM 00287Y109 22,991 2,019 9.63 2,480 5.00 1.4895
2021-07-29 2021-06-30 13F AbbVie COM 00287Y109 20,972 -176 -0.83 2,362 3.23 1.4771
2021-05-03 2021-03-31 13F AbbVie COM 00287Y109 21,148 -229 -1.07 2,288 -0.13 1.5829
2021-01-27 2020-12-31 13F AbbVie COM 00287Y109 21,377 2,030 10.49 2,291 35.16 1.7303
2020-10-26 2020-09-30 13F AbbVie COM 00287Y109 19,347 -1,327 -6.42 1,695 -16.46 1.4267
2020-07-14 2020-06-30 13F AbbVie COM 00287Y109 20,674 1,425 7.40 2,029 38.40 1.7857
2020-05-13 2020-03-31 13F AbbVie COM 00287Y109 19,249 3,657 23.45 1,466 6.23 1.5792
2020-01-27 2019-12-31 13F AbbVie COM 00287Y109 15,592 992 6.79 1,380 24.77 1.1682
2019-11-04 2019-09-30 13F AbbVie COM 00287Y109 14,600 3,126 27.24 1,106 32.61 1.0237
2019-08-14 2019-06-30 13F AbbVie COM 00287Y109 11,474 1,548 15.60 834 4.25 0.7117
2019-04-29 2019-03-31 13F AbbVie COM 00287Y109 9,926 437 4.61 800 -8.57 0.4120
2019-02-06 2018-12-31 13F Abbvie Inc USD 0.01 COM 00287Y109 9,489 517 5.76 875 3.06 0.5575
2018-11-13 2018-09-30 13F Abbvie Inc USD 0.01 COM 00287Y109 8,972 -420 -4.47 849 -2.41 0.4858
2018-08-14 2018-06-30 13F Abbvie Inc USD 0.01 COM 00287Y109 9,392 80 0.86 870 -1.36 0.5068
2018-05-11 2018-03-31 13F Abbvie Inc USD 0.01 COM 00287Y109 9,312 -1,026 -9.92 882 -11.80 0.5153
2018-02-20 2017-12-31 13F Abbvie Inc USD 0.01 COM 00287Y109 10,338 10,338 1,000 0.5980
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.